Clean Power Hydrogen (LSE:CPH2) has spent the second half of 2026 rebuilding its Business after a difficult year. The electrolyser developer published a "New Product Roadmap" announcement on 10 November 2026, following an investigation update in October into a testing incident and interim results in September that set out a shift towards a capital-light, licensing-led model.
What the company does
Clean Power Hydrogen develops electrolyser technology for producing hydrogen, centred on its membrane-free electrolyser design, including the 1MW MFE220 unit. The group has historically aimed to build and sell its own systems, but it now says it will focus on technology development and licensing rather than heavy in-house manufacturing.
Its partner relationships form part of that plan. In its interim results the company said it had signed non-binding memoranda of understanding with Siemens, Koch Modular Process Systems and ABE Gruppe. It also has a technology licence arrangement with Hidrigin.
Latest developments
The company's most recent announcement, released on 10 November 2026, set out a new product roadmap. Detailed contents of that statement were not available at the time of writing, so readers should consult the full announcement for specifics on products and timings.
On 19 October 2026 the company updated investors on its investigation into an incident that occurred during factory acceptance testing of an MFE220 electrolyser. The interim results had referred to an incident on 28 May 2026. According to the update, the investigation found no single ignition point and no fault in the company's proprietary stacks. Instead, it identified several contributing factors, including gas velocity, valve specification, system cleanliness and adherence to industry guidance. Remedial design work has begun and a revised design package is planned.
The same update said Clean Power Hydrogen and Hidrigin had agreed not to proceed with a secured convertible Loan note of about £750,000, and that an interim payment linked to it had been repaid. Talks are continuing about extending Hidrigin's technology licence to include own-use rights in the United States.
Earlier in the year the company carried out a conditional placing, subscription and retail offer, and trading in its shares was restored on AIM on 7 July 2026. Board changes were announced on 31 July 2026.
Financial and Dividend picture
For the six months to 30 June 2026, the company reported a loss of £4.9 million and held cash of about £0.2 million at the period end. It completed a fundraising on 20 July 2026 that brought in gross proceeds of £7.3 million. The group said it expects cash burn in the first quarter of 2027 to be around 70% lower than in the first quarter of 2026, reflecting restructuring and new leadership. No dividend has been declared, which is typical for a pre-profit technology developer.
Sector and index context
Hydrogen electrolyser developers have faced a challenging funding environment, with many smaller listed companies seeking to conserve cash and move towards Partnership or licensing models. Clean Power Hydrogen sits among the many early-stage clean energy names in the FTSE AIM All Share Index, where valuations tend to be sensitive to funding news and commercial milestones.
Key risks
The main risks include the company's reliance on external funding, the non-binding nature of its partner memoranda, and the need to complete remedial design work following the testing incident. Execution of the new licensing strategy is not yet proven, and further dilution remains possible if additional Capital is required.
What to watch next
Investors will look for roadmap detail, progress on the revised MFE220 design, binding partner agreements, the Hidrigin licence talks and evidence of lower cash burn.



_11_16_2026_13_52_03_442950.jpg)


Please wait processing your request...